PubMed (RefSeq) for id: 2462605432

Year	Number of Results
1990	1
1991	1
1992	1
1993	2
1994	1
1995	2
1996	2
1997	1
1999	2
2001	2
2002	4
2003	5
2004	5
2005	6
2006	14
2007	9
2008	15
2009	18
2010	18
2011	33
2012	32
2013	27
2014	22
2015	28
2016	25
2017	15
2018	14
2019	15
2020	18
2021	10
2022	7
2023	11
2024	4

1

The safety and potential efficacy of exosomes overexpressing CD24 (EXO-CD24) in mild-moderate COVID-19 related ARDS.

Grigoropoulos I, Tsioulos G, Kastrissianakis A, Shapira S, Green O, Rapti V, Tsakona M, Konstantinos T, Savva A, Kavatha D, Boumpas D, Syrigos K, Xynogalas I, Leontis K, Ntousopoulos V, Sakka V, Sardelis Z, Fotiadis A, Vlassi L, Kontogianni C, Levounets A, Poulakou G, Gaga M, MacLoughlin R, Stebbing J, Arber N, Antoniadou A, Tsiodras S. Grigoropoulos I, et al. Respir Res. 2024 Apr 1;25(1):151. doi: 10.1186/s12931-024-02759-5. Respir Res. 2024. PMID: 38561798 Free PMC article.

2

Checkpoint CD24 function on tumor and immunotherapy.

Huang S, Zhang X, Wei Y, Xiao Y. Huang S, et al. Front Immunol. 2024 Feb 29;15:1367959. doi: 10.3389/fimmu.2024.1367959. eCollection 2024. Front Immunol. 2024. PMID: 38487533 Free PMC article. Review.

3

Surprising magic of CD24 beyond cancer.

Wang H, Shi P, Shi X, Lv Y, Xie H, Zhao H. Wang H, et al. Front Immunol. 2024 Jan 19;14:1334922. doi: 10.3389/fimmu.2023.1334922. eCollection 2023. Front Immunol. 2024. PMID: 38313430 Free PMC article. Review.

4

High Expression and Significance of Siglec10/CD24 in Unexplained Missed Abortion.

Lin H, Gao L, Huang Y. Lin H, et al. Immunol Invest. 2023 Nov;52(8):997-1007. doi: 10.1080/08820139.2023.2279653. Epub 2023 Nov 24. Immunol Invest. 2023. PMID: 37933581

5

RARγ promotes the invasion and metastasis of thyroid carcinoma by activating the JAK1-STAT3-CD24/MMPs axis.

Zhang FX, Xu P, Zhang LJ, Fan R, Zhang HX, Liu DH, Liu K, Shen DY. Zhang FX, et al. Int Immunopharmacol. 2023 Dec;125(Pt A):111129. doi: 10.1016/j.intimp.2023.111129. Epub 2023 Oct 27. Int Immunopharmacol. 2023. PMID: 37897947 Free article.

6

Emerging Immune Checkpoint Molecules on Cancer Cells: CD24 and CD200.

Moon SY, Han M, Ryu G, Shin SA, Lee JH, Lee CS. Moon SY, et al. Int J Mol Sci. 2023 Oct 11;24(20):15072. doi: 10.3390/ijms242015072. Int J Mol Sci. 2023. PMID: 37894750 Free PMC article. Review.

7

Soluble CD24 is an inflammatory biomarker in early and seronegative rheumatoid arthritis.

Zheng X, Wang P, Song J, Tang Y, Xie Y, Jin X, Zhu D, Fang X, Wei C, Li R, Hu F, Li Z. Zheng X, et al. Ann Med. 2023;55(2):2246370. doi: 10.1080/07853890.2023.2246370. Ann Med. 2023. PMID: 37591778 Free PMC article.

8

The biological roles of CD24 in ovarian cancer: old story, but new tales.

Gu Y, Zhou G, Tang X, Shen F, Ding J, Hua K. Gu Y, et al. Front Immunol. 2023 Jun 9;14:1183285. doi: 10.3389/fimmu.2023.1183285. eCollection 2023. Front Immunol. 2023. PMID: 37359556 Free PMC article. Review.

9

Prognostic Implications of CD24, SOX2, and Nanog Expression in Invasive Urothelial Carcinoma.

Abdelbary AM, Atwa HA, Elfarargy OM, Qasem ER, Elaidy NF. Abdelbary AM, et al. Appl Immunohistochem Mol Morphol. 2023 Jul 1;31(6):421-428. doi: 10.1097/PAI.0000000000001134. Epub 2023 Jun 7. Appl Immunohistochem Mol Morphol. 2023. PMID: 37278276

10

CD24 targeting with NK-CAR immunotherapy in testis, prostate, renal and (luminal-type) bladder cancer and identification of direct CD24 interaction partners.

Söhngen C, Thomas DJ, Skowron MA, Bremmer F, Eckstein M, Stefanski A, Driessen MD, Wakileh GA, Stühler K, Altevogt P, Theodorescu D, Klapdor R, Schambach A, Nettersheim D. Söhngen C, et al. FEBS J. 2023 Oct;290(20):4864-4876. doi: 10.1111/febs.16880. Epub 2023 Jun 26. FEBS J. 2023. PMID: 37254618

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

320 results

Results by year